Awareness and attitudes of oncology specialists toward dihydropyrimidine dehydrogenase testing in Saudi Arabia

BACKGROUND: Fluoropyrimidines (FP) are among the most common class of prescribed anti‐neoplastic drugs. This class has severe to moderate toxicity in around 10%–40% of those who take 5‐fluorouracil (5‐FU) or capecitabine for the treatment of cancer. In practice many patients with severe toxicities f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukkarieh, Hatouf H., AlSagoor, Turki, Alnuhait, Mohammed, Bustami, Rami, Bryson, Scott, Adem, Fatima Mohammed Kebir, Abdalla, Hana, Karbani, Gulsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939998/
https://www.ncbi.nlm.nih.gov/pubmed/36806724
http://dx.doi.org/10.1002/cnr2.1704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939998/
https://www.ncbi.nlm.nih.gov/pubmed/36806724
http://dx.doi.org/10.1002/cnr2.1704

Ejemplares similares